Advertisement

Topics

Rituxan (rituximab)

23:07 EST 12th December 2018 | BioPortfolio

Non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis

2012 sales: $7.285 billion (CHF 6.707 billion)

Drug maker: Roche

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Rituxan (rituximab) market research data and corporate reports here